Skip to main content

Table 3 Newly additional medications after the allocation

From: The effect of dapagliflozin treatment on epicardial adipose tissue volume

  Dapagliflozin (n = 20) Conventional therapy (n = 20)
SGLT-2 inhibitor 20 (100) 0
α-GI 0 (0) 3 (15)
DPP-4 inhibitor 0 (0) 14 (70)
Biguanide 0 (0) 1 (5)
Sulfonyl urea 0 (0) 1 (5)
Glinide 0 (0) 1 (5)
Pioglitazone 0 (0) 0
  1. Data are presented as the number (percentage)
  2. SGLT-2 sodium-glucose co-transporter-2, α-GI α-glucosidase inhibitors, DPP-4 dipeptidyl peptidase-4